Australian scientists will kickstart research into how early vaccine studies can safely support faster approvals of vaccines in response to infectious disease outbreaks. FEEVA (a Framework for Evidence Evaluation in Vaccine Assessment) is a new collaborative project led by the Kirby Institute at UNSW Sydney and ALEC, supported by $3.9m AUD in funding from global health organisations CEPI and Wellcome....